An Introduction to NVIDIA BioNeMo - our story behind the webinar
- Steve Quenette
- Apr 17
- 2 min read
Our recent BPA landscape analysis of AI & AI-era strategy - consultation & strategy summary aimed to disseminate some key findings and, in turn, empower the community to progress with well-considered AI-era agendas. One of the three key recommendations was to "entrain to catch up" - what better way to achieve this than to connect the mover-and-shaker NVIDIA? Australia's omics research community need to create, needs the potential for opportunity, needs processing power, and needs wares, and NVIDIA has a decadal track record of enabling all these things. This is our story behind the latest NVIDIA BioNemo webinar.
Connecting the Bioplatforms Australia (Australian omics research) community to NVIDIA's experiences and pathways was an early entrain to catch up activity. Establishing these connections is something we're uniquely placed to do.
Premised on the idea that NVIDIA has driven the AI boom:
NVIDIA helped OpenAI with ChatGPT by engineering the hardware and software (and approach) to scale out AI computation
They bundled this software - Nemo & NIM, making it available for others!
#BioNemo applies the Nemo/NIM concept for biology, specifically early-phase drug discovery AI pipelines
... it was clear the local community could learn from this fundamentally different approach.
During the week of eResearch Australasia 2024, BPA hosted a first-in-region webinar, presented by NVIDIA, entitled Advancing Biomedical Research with Cutting-Edge AI.
Within a day, 80 people had registered.
Within a week, 155 people had registered!
A delivery re-think was necessary to open the gates to more.
These factors culminate in the webinar missing from the NVIDIA and BPA libraries (we have an archive of the webinar - reach out to access it). However, since then, the recent NVIDIA GTC had 112 presentations, posters and other events tagged as "Healthcare & Life-science". The momentum and ecosystem is growing!
You can now get an introduction and condensed update by attending NVIDIA's second in-region health/life-sciences AI webinar on Tuesday, April 29.
Entitled - The Future of Drug Discovery: An Introduction to NVIDIA BioNeMo, the webinar will explore the key components of BioNeMo (the technology), including its open-source framework, NIM microservices, blueprints, and pre-trained AI models for tasks such as protein structure prediction, molecular docking, and small molecule generation. The showcase is inspiring, with Nanyang Biologics, WeComput and TandemAI drug discovery applications. This time Ying-Ja Chen is supported by Tran Minh Quan, Prateek Jain and Tianjing (Steve) Zhang.
Click through to register to the webinar - if the first webinar was any indication, the spots will fill up fast!
